Research and Clinical Trials, Skin Cancer/Melanoma

Meet the investigator: Roxana S. Dronca, M.D.

By Nicole Ferrara • September 12, 2018
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Roxana S. Dronca, M.D., a hematologist and an oncologist at Mayo Clinic in Jacksonville, Florida, discusses her research on tumor immunology, malignant melanoma and genitourinary malignancies.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer genitourinary immunology malignancies melanoma research Research and Clinical Trials Skin Cancer/Melanoma tumor
Subscribe
Request an Appointment
Find a Clinical Trial
Brentuximab vedotin may improve overall survival in patients with Hodgkin Lymphoma

Researchers found that the addition of brentuximab vedotin to standard chemotherapy improves overall survival in people with Hodgkin Lymphoma.

AI applied to prediagnostic CTs may help diagnose pancreatic cancer at earlier, more treatable stage

Study finds radiomics-based machine learning models may detect pancreatic cancer on CT scans earlier than current methods for diagnosis.

Dawn’s journey: Overcoming a near-zero survival rate

The story of how Dawn Botsford conquered melanoma with the support of her family, her Mayo Clinic care team and a clinical trial.